Generic and brand-name drugs D

Generic and brand-name drugs D: Composition, drug form and content, indications, contraindications, precautions, unwanted effects, dosage and administration, interactions, storage

Demerol: Narcotic analgesics

If you use Demerol while you are pregnant, your baby could become dependent on the drug. This can cause life-threatening withdrawal symptoms in the baby after it is born.

Dayvigo: Treatment for Insomnia

Dayvigo is a federally controlled substance because it can be abused or cause dependence. Keep Dayvigo in a safe place to prevent misuse and abuse.

Darzalex: Monoclonal antibodies

Darzalex is sometimes used in combination with lenalidomide, pomalidomide, or thalidomide. Both men and women using these other drugs must use effective birth control.

Dapagliflozin: Sodium-glucose Cotransporter 2 Inhibitors

Initial dosage based on patient's current regimen with dapagliflozin and/or metformin hydrochloride. May gradually increase the dosage based on effectiveness and tolerability.

Doxorubicin Bidiphar: Anthracycline cancer treatment drug

Doxorubicin is an anthracycline antineoplastic agent that can be used alone or in combination with other antineoplastic agents. Cross-resistance occurs when the tumor is resistant to both doxorubicin and daunorubicin.

Doxorubicin Ebewe: Treatment cancer of the hematopoietic system, lymphatic system

Doxorubicin has been shown to have anti-neoplastic activity in several animal species and is effective in humans, but there is still no consensus on how doxorubicin and other anthracyclines exert antitumor effects.

Dronagi: Medicine to treat and prevent osteoporosis

Risedronate belongs to a class of non-steroidal drugs called bisphosphonates, which are used to treat bone diseases. Risedronate is a pyridinil bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-induced bone resorption.

Docetaxel Ebewe: Cancer treatment drug

Docetaxel has shown cytotoxic activity against several tumor cell lines, is independent and has broad-spectrum antitumor activity in vitro in transplanted human and murine advanced tumors.

Dompil: medicine to treat symptoms of vomiting and nausea

Dompil is indicated for the symptomatic treatment of vomiting and nausea, especially in patients undergoing cytotoxic therapy, or when there is a feeling of epigastric distension and heaviness, postprandial dyspepsia due to delayed food intake.